Stock 9960 KINDSTAR GLOBALGENE TECHNOLOGY, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Kindstar Globalgene Technology, Inc.

Equities

9960

KYG5262E1044

Healthcare Facilities & Services

Market Closed - Hong Kong S.E.
Other stock markets
 04:08:20 2024-04-26 am EDT 		5-day change 1st Jan Change
1.6 HKD +2.56% Intraday chart for Kindstar Globalgene Technology, Inc. +3.90% -4.76%
Mar. 27 Kindstar Globalgene Technology, Inc. Proposes Final Dividend for the Year Ended 31 December 2023, Payable on 27 September 2024 CI
Mar. 27 Kindstar Globalgene Technology, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Valuation

Fiscal Period: December 2021 2022 2023 2024 2025
Capitalization 1 4,210 2,471 1,411 1,411 -
Enterprise Value (EV) 1 1,994 718.8 1,464 1,411 1,411
P/E ratio -1.59 x 27.4 x 35.9 x 13.5 x 11.4 x
Yield - - - - -
Capitalization / Revenue 4.52 x 1.78 x 1.51 x 1.07 x 0.88 x
EV / Revenue 4.52 x 1.78 x 1.51 x 1.07 x 0.88 x
EV / EBITDA 53,057,108 x 21,962,565 x - - -
EV / FCF -19,705,173 x - - - -
FCF Yield -0% - - - -
Price to Book 1.55 x 0.84 x 0.39 x 0.37 x 0.35 x
Nbr of stocks (in thousands) 901,611 978,305 952,410 952,410 -
Reference price 2 4.669 2.526 1.481 1.481 1.481
Announcement Date 3/25/22 3/27/23 3/27/24 - -
1CNY in Million2CNY
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2020 2021 2022 2023 2024 2025
Net sales 1 - 930.7 1,387 967.3 1,321 1,611
EBITDA - 79.34 112.5 - - -
EBIT - 43.69 60.86 - - -
Operating Margin - 4.69% 4.39% - - -
Earnings before Tax (EBT) 1 - -1,454 83.32 43.32 130 156
Net income 1 -974 -1,454 75.46 41.29 110 133
Net margin - -156.28% 5.44% 4.27% 8.33% 8.26%
EPS 2 -8.690 -2.930 0.0922 0.0425 0.1100 0.1300
Free Cash Flow - -213.6 - - - -
FCF margin - -22.95% - - - -
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share - - - - - -
Announcement Date 6/29/21 3/25/22 3/27/23 3/27/24 - -
1CNY in Million2CNY
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 S1 2021 S2 2022 S1 2022 S2 2023 S1
Net sales 1 438.2 492.5 659.5 727.1 492.8
EBITDA - - - - -
EBIT 1 26.98 16.71 49.58 11.28 -17.7
Operating Margin 6.16% 3.39% 7.52% 1.55% -3.59%
Earnings before Tax (EBT) - - - - -
Net income - - - - -
Net margin - - - - -
EPS 2 -10.33 7.400 0.0600 0.0322 0.0500
Dividend per Share - - - - -
Announcement Date 8/30/21 3/25/22 8/15/22 3/27/23 8/18/23
1CNY in Million2CNY
Estimates

Balance Sheet Analysis

Fiscal Period: December 2020 2021 2022 2023 2024 2025
Net Debt - - - - - -
Net Cash position - 2,216 1,752 - - -
Leverage (Debt/EBITDA) - - - - - -
Free Cash Flow - -214 - - - -
ROE (net income / shareholders' equity) - 18.5% 2.72% 2.4% 2.7% 3.1%
ROA (Net income/ Total Assets) - 3.4% - - - -
Assets 1 - -42,765 - - - -
Book Value Per Share 2 - 3.020 3.020 3.820 4.020 4.240
Cash Flow per Share 2 - 0.1400 0.0300 0.6900 0.6500 0.7500
Capex 1 - 282 120 791 806 800
Capex / Sales - 30.26% 8.63% 73.04% 61.01% 49.66%
Announcement Date 6/29/21 3/25/22 3/27/23 3/27/24 - -
1CNY in Million2CNY
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Ratings for Kindstar Globalgene Technology, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
1.6
Average target price
-
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Medical & Diagnostic Laboratories

1st Jan change Capi.
KINDSTAR GLOBALGENE TECHNOLOGY, INC. Stock Kindstar Globalgene Technology, Inc.
-4.76% 195M
SONIC HEALTHCARE LIMITED Stock Sonic Healthcare Limited
-17.89% 8.25B
RADNET, INC. Stock RadNet, Inc.
+39.20% 3.58B
GUANGZHOU KINGMED DIAGNOSTICS GROUP CO., LTD. Stock Guangzhou Kingmed Diagnostics Group Co., Ltd.
-39.11% 2.46B
SYNLAB AG Stock SYNLAB AG
-8.06% 2.46B
DR. LAL PATHLABS LIMITED Stock Dr. Lal PathLabs Limited
-7.35% 2.38B
FLEURY S.A. Stock Fleury S.A.
-19.01% 1.55B
DIAN DIAGNOSTICS GROUP CO.,LTD. Stock Dian Diagnostics Group Co.,Ltd.
-40.66% 1.21B
METROPOLIS HEALTHCARE LIMITED Stock Metropolis Healthcare Limited
+7.56% 1.11B
ADICON HOLDINGS LIMITED Stock Adicon Holdings Limited
-15.34% 1.03B
Medical & Diagnostic Laboratories
  1. Stock Market
  2. Equities
  3. 9960 Stock
  4. Financials Kindstar Globalgene Technology, Inc.